Issue 0 · published August 16, 2026
Collection window: August 8, 2026–August 14, 2026. This issue distinguishes records dated at their source during the week from older records newly added to PeptideScanner.
Change ledger for this window
This deterministic view contains 2220 collection or version events: 2220 record additions and 0 preserved version changes. Source dates remain separate.
PeptideScanner retained ClinicalTrials.gov record NCT00427349 at 2026-07-30T19:10:42.711Z. Its registry update date was 2023-07-05, and PeptideScanner's reviewed identity mapping was octreotide.
PeptideScanner retained ClinicalTrials.gov record NCT00569127 at 2026-08-10T18:10:03.946Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was octreotide.
PeptideScanner retained ClinicalTrials.gov record NCT00608023 at 2026-07-30T19:35:26.307Z. Its registry update date was 2022-09-30, and PeptideScanner's reviewed identity mapping was tesamorelin.
Complete window counts
Source activity
These 74 records carry a cited source date from August 8, 2026 through August 14, 2026.
Clinical trials · source date August 13, 2026
PeptideScanner retained ClinicalTrials.gov record NCT07087795 at 2026-08-13T16:32:13.881Z. Its registry update date was 2026-08-13, and PeptideScanner's reviewed identity mapping was semaglutide.↗
Added August 14, 2026 · SemaglutideLiterature metadata · source date August 14, 2026
PubMed lists PMID 42597211 in Frontiers in psychiatry as Case Reports, Journal Article, with publication-date metadata of 2026-07-30 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Added August 14, 2026 · LiraglutideClinical trials · source date August 12, 2026
PeptideScanner retained ClinicalTrials.gov record NCT03883412 at 2026-08-13T05:54:14.859Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was liraglutide.↗
Added August 14, 2026 · LiraglutideLiterature metadata · source date August 14, 2026
PubMed lists PMID 42598502 in JAAD case reports as Letter, with publication-date metadata of 2026-06-17 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Added August 14, 2026 · TirzepatideClinical trials · source date August 12, 2026
PeptideScanner retained ClinicalTrials.gov record NCT05478707 at 2026-08-13T05:54:14.860Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was dulaglutide.↗
Added August 14, 2026 · DulaglutideLiterature metadata · source date August 13, 2026
PubMed lists PMID 31408164 in The Journal of clinical endocrinology and metabolism as Comment, Letter, with publication-date metadata of 2019-12-01 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Added August 14, 2026 · TeriparatideHistorical coverage
These 2146 records were added during the collection window but carry a source date before August 8, 2026.
Clinical trials · added August 14, 2026
PeptideScanner retained ClinicalTrials.gov record NCT06739122 at 2026-08-13T05:52:27.010Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was dulaglutide.↗
Source date August 7, 2026 · DulaglutideLiterature metadata · added August 10, 2026
PeptideScanner retained PubMed bibliographic metadata for PMID 33491091 at 2026-08-10T10:49:06.839Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2021-01-25. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.↗
Source date August 7, 2026 · GlucagonRegulatory · added August 14, 2026
The official Drugs@FDA dataset lists original submission 1 for ANDA 212972 with status AP dated 2026-07-01, and names liraglutide among the application record's active ingredients.↗
Source date July 1, 2026 · LiraglutideClinical trials · added August 14, 2026
PeptideScanner retained ClinicalTrials.gov record NCT07313761 at 2026-08-13T05:52:27.026Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.↗
Source date August 7, 2026 · Maridebart cafraglutideLiterature metadata · added August 10, 2026
PeptideScanner retained PubMed bibliographic metadata for PMID 38240127 at 2026-08-10T10:49:06.873Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2024-01-19. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.↗
Source date August 7, 2026 · LiraglutideRegulatory · added August 14, 2026
The official Drugs@FDA dataset lists original submission 1 for ANDA 213155 with status AP dated 2026-06-15, and names liraglutide among the application record's active ingredients.↗
Source date June 15, 2026 · LiraglutideCollection shape
These counts describe records added to PeptideScanner, not popularity, importance, research quality, or clinical evidence strength.